NCI’s CPTAC Releases an Openly Accessible Data Set Primed for Multi-omic Integration

On September 4, 2013, NCI’s Clinical Proteomics Tumor Analysis Consortium (CPTAC) publicly released proteomic data produced from colorectal tumor samples previously analyzed as part ofThe Cancer Genome Atlas (TCGA) initiative. This is the first release of proteomic tumor data designed to complement genomic data from the same tumors.


Since its launch in 2006, the Consortium has “aimed at improving proteomic analysis platforms to reliably identify, quantify, and compare proteins and peptides in complex biological mixtures.” After five years of technology development, inter-laboratory studies, and statistical analyses of variation, the program entered a second phase, this time focused on data production. CPTAC obtained access to a subset of tumors analyzed by TCGA, with a view toward generating proteomic data sets to enable integration with the genomic data.


The CPTAC consists of five teams that create a network of Proteome Characterization Centers (PCCs):

  • Broad Institute; Fred Hutchinson Cancer Research Center
  • Johns Hopkins University
  • Pacific Northwest National Laboratory
  • Vanderbilt University
  • Washington University; University of North Carolina, Chapel Hill


Share this Article with others

By Sorena Nadaf April 17, 2025
Caught in the crossfire: The critical threats facing cancer centers, research, and patient care. Shannon McWeeney PhD, & Sorena Nadaf-Rahrov MS, MMI
By Sorena Nadaf February 13, 2025
January 2025 Newsletter: The Year of Artificial Intelligence Sorena Nadaf-Rahrov, MS, MMI, PhDc
By Sorena Nadaf February 5, 2025
A recent Lancet study demonstrated that AI implementation led to a 29% increase in cancer detection, with no increase in false positives and a reduced workload compared to radiologists without AI assistance. While emerging evidence supports AI’s potential to enhance cancer detection in mammography screening and reduce screen-reading workload, further research is needed to fully understand its clinical impact.
By Sorena Nadaf December 10, 2024
Artificial intelligence to empower diagnosis of myelodysplastic syndromes by multiparametric flow cytometry
By Sorena Nadaf November 11, 2024
With heavy hearts, we remember and honor Brady Davis, whose sudden passing leaves an immense void. Brady was a devoted supporter and invaluable contributor to the Cancer Center Informatics Society, dedicating countless hours to advancing our mission and strengthening our community. His expertise, enthusiasm, and unwavering commitment shaped our initiatives and inspired everyone fortunate enough to work alongside him. Brady’s legacy will live on through the progress he championed and the connections he fostered. We extend our deepest sympathies to his family, friends, and all who knew him. He will be greatly missed. In honor of Brady’s legacy, Ci4CC will be forming a committee to explore meaningful ways to memorialize him within our society for years to come. We plan to announce the committee’s recommendations at our Spring Summit in San Diego, CA, on March 31, 2025. Please find his obituary here , and visit his memorial page on MyKeeper to leave a tribute. Support the Davis family in Brady’s memory via GoFundMe ---------- Cancer Center Informatics Society (Ci4CC) Sorena Nadaf-Rahrov & Warren Kibbe Co-Founders, Ci4CC
By Sorena Nadaf October 29, 2024
Nature Digital Medicine PRISM: Patient Records Interpretation for Semantic clinical trial Matching system using large language models
By Sorena Nadaf September 4, 2024
American Cancer Society and Color Health to Provide Free At-Home Colorectal Cancer Screening in Underserved Rural Communities
September 4, 2024
Leading Progress Against Cancer
August 24, 2024
By Drs Karen Knudsen & Othman Laraki.
By Sorena Nadaf July 18, 2024
Conversation with The Cancer Letter: NCI’s new chief data scientist Warren Kibbe tells us about efforts to get “AI-ready” - July 12, 2024